在线粒体膜上发现的GPCRs:对于疾病的新治疗点
Yanxin Pan1, Ning Ji1, Lu Jiang1
1State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, Chinese Academy of Medical Sciences Research Unit of Oral Carcinogenesis and Management, West China Hospital of Stomatology, Sichuan University, Chengdu, 610041, China.
Journal of pharmaceutical analysis
|July 25, 2025
概括
线粒体G蛋白结合受体 (mGPCRs) 调节关键细胞功能,并与糖尿病和阿尔茨海默氏症等疾病有关. 了解mGPCRs为代谢和神经退行性疾病提供了新的治疗点.
科学领域:
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- G蛋白结合受体 (GPCRs) 是一个庞大的膜蛋白家族,对细胞信号传递至关重要.
- 传统上以血的作用而闻名,GPCRs在线粒体上越来越多地被识别.
- 线粒体GPCRs (mGPCRs) 影响重要的细胞过程,包括能量代谢和亡.
研究的目的:
- 审查在线粒体膜上发现的GPCR类型.
- 分析mGPCRs与疾病发病的关系.
- 为了突出mGPCRs的治疗潜力.
主要方法:
- 关于线粒体GPCRs研究的文献综述.
- 对线粒体膜上GPCR局部化的分析.
- 在各种疾病模型中检查mGPCR角色.
主要成果:
- GPCRs存在于线粒体上,调节呼吸,ROS产生和亡.
- mGPCR功能障碍与心血管疾病,糖尿病,肥胖和阿尔茨海默病有关.
- mGPCRs代表了线粒体内的新信号层.
结论:
- 线粒体GPCRs是细胞功能和能量恒温的关键调节者.
- mGPCRs的调节失调对主要系统性疾病的发病有显著的贡献.
- 向mGPCRs是治疗线粒体功能障碍相关疾病的有希望的治疗策略.
相关概念视频
G Protein-coupled Receptors
13.5K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
13.5K
Transducer Mechanism: G Protein–Coupled Receptors
2.4K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
2.4K
Mitochondrial Precursor Proteins
2.6K
Mitochondrial precursors are partially unfolded or loosely folded polypeptide chains. Newly synthesized precursors are inhibited from spontaneously folding into their native conformation by the cytosolic chaperones, heat shock proteins 70 (Hsp70), and mitochondrial import stimulation factors (MSFs). Precursors bound to MSFs are guided to the TOM70-TOM37 receptors, while precursors bound to Hsp70 chaperones are targetted to TOM20-TOM22 receptor complexes.
Most of the mitochondrial...
Most of the mitochondrial...
2.6K
Electron Transport Chain: Complex I and II
15.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.0K
Targets for Drug Action: Overview
7.4K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.4K
Transducer Mechanism: Enzyme-Linked Receptors
2.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.8K


